Protein Laboratories Rehovot

Production of Biologically Active Recombinant Proteins

Health Tech & Life Sciences
Non Active, Dec 2025 ceased to operate
Mature Rehovot Founded 2003
LinkedIn
Total raised
Stage
Mature
Founded
2003
Headcount
5
HQ
Rehovot
Sector
Health Tech & Life Sciences

About

Protein Laboratories Rehovot (PLR) produces biologically active recombinant proteins, mainly different cytokines and their soluble receptors, in E. coli. PRL executes the entire process and plans an optimized sequence, over-expressing it as an insoluble protein, purifying the inclusion bodies, and finally refolding it as a biologically active protein and purifying to over 98% homogeneity by ion exchange or gel filtration chromatography. The proteins are tested for purity to allow determination of biologically active active monomers or dimers under non-denaturing conditions. The company is owned by Professor Arieh Gertler, the Karl Bach Chair in Agricultural Biochemistry of the Hebrew University and Mr. Gopal Savjani from Houston, TX. PRL is licensed by the Hebrew University and Yissum.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentBiomaterials & Tissue Engineering
Technologies
Biologicals
Target customers
ConsumersEducation & AcademiaResearchersHealthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Tags

proteinspatientspharmaceuticalspharma-companiesacademiagenetic-disorders